255 Spam-Free Article(s) Found
Jul 21, 2016 - The combination of Lilly's Zacks Rank #3 and +1.18% ESP makes us very confident in looking for a positive earnings beat on Jul 26.
Sep 17, 2015 - Incyte Corporation (NASDAQ:INCY) Morgan Stanley 2015 Global Healthcare Conference Call September 17, 2015 12:20 PM ET Executives Herve Hoppenot – President and Chief Executive Officer Analysts Andrew
Sep 11, 2015 - Aduro (ADRO) signed a clinical study agreement with Incyte (INCY) to evaluate CRS-207, in combination with Incyte's epacadostat, in patients with ovarian cancer.
Sep 04, 2015 - The positive earnings estimate revisions suggest that analysts are becoming more optimistic on Incyte Corporation’s earnings for the coming quarter and year
Sep 03, 2015 - Incyte (INCY) signs an agreement with Hengrui to develop and commercialize an anti-PD-1 monoclonal antibody, SHR-1210.